Product Name
cerebral cavernous malformation 2 (CCM2), ELISA Kit
Full Product Name
Mouse Malcavernin, CCM2 ELISA Kit
Product Synonym Names
Mouse Malcavernin (CCM2) ELISA kit; C7orf22; MGC4067; MGC4607; MGC74868; OSM; PP10187; malcavernin; cerebral cavernous malformation 2
Product Gene Name
CCM2 elisa kit
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Request for Current Manual Insert
Request Current Manual
3D Structure
ModBase 3D Structure for Q8K2Y9
Preparation and Storage
Store all reagents at 2-8 degree C
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual.
Other Notes
Small volumes of CCM2 elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for CCM2 purchase
MBS9320806 is a ready-to-use microwell, strip plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the cerebral cavernous malformation 2 (CCM2) ELISA Kit target analytes in
biological samples. The concentration gradients of the kit standards or positive controls render a theoretical kit detection range in biological research samples containing CCM2. The ELISA analytical biochemical technique of the MBS9320806 kit is based on CCM2 antibody-CCM2 antigen interactions (immunosorbency) and an HRP colorimetric detection system to detect CCM2 antigen targets in samples. The ELISA Kit is designed to detect native, not recombinant, CCM2. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, secretions. Quality control assays assessing reproducibility identified the intra-assay CV (%) and inter-assay CV(%).
NCBI/Uniprot data below describe general gene information for CCM2. It may not necessarily be applicable to this product.
NCBI Accession #
NP_666126.1
[Other Products]
NCBI GenBank Nucleotide #
NM_146014.3
[Other Products]
UniProt Primary Accession #
Q8K2Y9
[Other Products]
UniProt Secondary Accession #
Q5SUA3[Other Products]
UniProt Related Accession #
Q8K2Y9[Other Products]
Molecular Weight
48,248 Da
NCBI Official Full Name
malcavernin isoform 1
NCBI Official Synonym Full Names
cerebral cavernous malformation 2
NCBI Official Symbol
Ccm2??[Similar Products]
NCBI Official Synonym Symbols
BC029157
??[Similar Products]
NCBI Protein Information
malcavernin; osmosensing scaffold for MEKK3; cerebral cavernous malformation 2 homolog; cerebral cavernous malformations protein 2 homolog
UniProt Protein Name
Malcavernin
UniProt Synonym Protein Names
Cerebral cavernous malformations protein 2 homolog; Osmosensing scaffold for MEKK3
Protein Family
Cerebral cavernous malformations protein
UniProt Gene Name
Ccm2??[Similar Products]
UniProt Synonym Gene Names
Osm??[Similar Products]
UniProt Entry Name
CCM2_MOUSE
UniProt Comments for CCM2
CCM2: Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. May act through the stabilization of endothelial cell junctions. May function as a scaffold protein for MAP2K3-MAP3K3 signaling. Seems to play a major role in the modulation of MAP3K3- dependent p38 activation induced by hyperosmotic shock. Defects in CCM2 are the cause of cerebral cavernous malformations type 2 (CCM2). Cerebral cavernous malformations (CCMs) are congenital vascular anomalies of the central nervous system that can result in hemorrhagic stroke, seizures, recurrent headaches, and focal neurologic deficits. CCMs have an incidence of 0.1%-0.5% in the general population and are usually present clinically during the 3rd to 5th decades of life. The lesions are characterized by grossly enlarged blood vessels consisting of a single layer of endothelium and without any intervening neural tissue, ranging in diameter from a few millimeters to several centimeters. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Adaptor/scaffold; Motility/polarity/chemotaxis
Cellular Component: protein complex; cytoplasm
Molecular Function: protein binding
Biological Process: pericardium development; blood vessel development; intercellular junction assembly and maintenance; venous blood vessel morphogenesis; vasculature development; in utero embryonic development; multicellular organism growth; heart development; vasculogenesis; inner ear development; endothelial cell development
Research Articles on CCM2
1. Down-modulation of STK25, but not STK24, rescued medulloblastoma cells from NGF-induced TrkA-dependent cell death, suggesting that STK25 is part of the death-signaling pathway initiated by TrkA and CCM2.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.